Deep Brain Stimulation Clinical Trial
Official title:
Determination of EC50 of Anesthetics During Microelectric Recording in Patients Receiving Deep Brain Stimulation Under Anesthesia
The investigators determine the half maximum effective concentration (EC50) of the Cet value of propofol in target-controlled infusion (TCI) when co-administered with dexmedetomidine for the maintenance of general anesthesia during microelectrode recording in the deep brain surgery in patients with Parkinson's disease.
General anesthesia is sometimes required for DBS (deep brain stimulation) surgery in those with excessive fear, anxiety, reduced cooperation, or severe movements due to ' off drug' state. Dexmedetomidine and propofol are both used individually in the sedation for DBS surgery, and were reported to affect the MER (microelectrode recording) to some extent, especially in the higher zone of the dose range. In this study, the investigators plan to use the combination of dexmedetomidine and propofol for the maintenance of general anesthesia in patients with Parkinson's disease. In this study, dexmedetomidine is given with a loading dose of 0.5 mcg/Kg, and continuous infusion with the dose of 0.4 mcg/Kg/hr. Propofol is given within 0.8~1.8 mcg/Kg during the MER recording (based on institutional guideline). MER recording will be observed and correlated wtih the dose of propofol. The Dixon "up-and-down" sequential allocation method was used to determine the EC50 of the value of Cet of propofol. The study aims to determine the dose that is adequate for maintaining general anesthesia with endotracheal intubation and least interference with the MER recording. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03795935 -
Relief From Side Effects: Clinical Use of Electrodes With Direction
|
N/A | |
Recruiting |
NCT05493722 -
Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy
|
Early Phase 1 | |
Recruiting |
NCT03221023 -
Intrawound Vancomycin Prophylaxis for Neural Stimulator
|
Phase 2/Phase 3 | |
Recruiting |
NCT05968976 -
Multicentre RCT of Awake Versus Asleep Tractography Based DBS for ET
|
N/A | |
Recruiting |
NCT05417555 -
Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05022147 -
Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease
|
Phase 1 | |
Recruiting |
NCT06078397 -
Remote Programming for Deep Brain Stimulation in Parkinson's Disease.
|
N/A | |
Recruiting |
NCT05065151 -
Understanding Motivation in Parkinson's Patients Through Neurophysiology
|
N/A | |
Completed |
NCT02947841 -
The Effectiveness of Alternating Stimulation in Preventing Tolerance in Essential Tremor Patients
|
N/A | |
Recruiting |
NCT05774041 -
Visualization of the STN and GPi for DBS
|
||
Recruiting |
NCT06112067 -
Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders
|
N/A | |
Recruiting |
NCT05550714 -
Choice of Anesthesia in Microelectrode Recording Guided Deep Brain Stimulation for Parkinson's Disease
|
N/A | |
Completed |
NCT03696420 -
Probabilistic Targeting of the VIM
|
||
Not yet recruiting |
NCT06121947 -
Safety and Efficacy Study of Implantable Neuromodulation for Poststroke Hemiplegia
|
N/A | |
Active, not recruiting |
NCT03347084 -
Deep Brain Stimulation With LIFUP for Mild Cognitive Impairment and Mild Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05097001 -
Dystonia Image-based Programming of Stimulation: A Prospective, Randomized, Double-blind Crossover Trial
|
N/A | |
Recruiting |
NCT05905198 -
Programming Strategy of VFS for Gait Impairments in PD
|
N/A | |
Recruiting |
NCT02982512 -
Dexmedetomidine on Basal Ganglia Neuronal Activity in Parkinson's Disease
|
Phase 4 | |
Recruiting |
NCT05568199 -
Udall Project 1 Aim 4
|
||
Active, not recruiting |
NCT04530942 -
The Efficacy and Prediction of Deep Brain Stimulation for Treatment-resistant Depression
|
N/A |